For research use only. Not for therapeutic Use.
NF-κB Activation Inhibitor III(CAT: I011679) is a small molecule inhibitor that targets the activation of nuclear factor kappa B (NF-κB), which is a transcription factor that plays a critical role in the regulation of immune and inflammatory responses. By inhibiting the activation of NF-κB, NF-κB Activation Inhibitor III can modulate the immune and inflammatory responses and has potential therapeutic applications in the treatment of inflammatory diseases and cancer.
Catalog Number | I011679 |
CAS Number | 380623-76-7 |
Synonyms | 3-chloro-4-nitro-N-(5-nitro-2-thiazolyl)-benzamide |
Molecular Formula | C10H5ClN4O5S |
Purity | ≥95% |
Target | MAPK/ERK Pathway |
Solubility | Soluble in DMSO |
Storage | Store at 4°C |
IUPAC Name | 3-chloro-4-nitro-N-(5-nitro-1,3-thiazol-2-yl)benzamide |
InChI | InChI=1S/C10H5ClN4O5S/c11-6-3-5(1-2-7(6)14(17)18)9(16)13-10-12-4-8(21-10)15(19)20/h1-4H,(H,12,13,16) |
InChIKey | XCHLNGBTHLJLFG-UHFFFAOYSA-N |
SMILES | C1=CC(=C(C=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-])Cl)[N+](=O)[O-] |